MRP1 not MDR1 gene expression is the predominant mechanism of acquired multidrug resistance in two prostate carcinoma cell lines

Prostate Cancer and Prostatic Diseases

Volumn 3, Issue 2, 2000, Pages 66-75

  Zalcberg, J ^a   Hu, X F ^a   Slater, A ^a   Parisot, J ^a   El Osta, S ^a   Kantharidis, P ^a   Chou, S T ^b   Parkin, J D ^b  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b AUSTIN HEALTH   (Australia)

Author keywords

Drug resistance; Expression; MDR1; MRP1; Prostate cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; COMPLEMENTARY DNA; DAUNORUBICIN; DOXORUBICIN; EPIRUBICIN; MITOXANTRONE; RNA; TRITIUM; VERAPAMIL; VINBLASTINE;

ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CHEMOSENSITIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; NORTHERN BLOTTING; PRIORITY JOURNAL; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0033849017     PISSN: 13657852     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.pcan.4500394     Document Type: Article

References (49)

1. Cancer statistics
2. Management of relapsing disease in prostate cancer
3. Mitoxantrone, a review of its pharmacology and clinical efficacy in the management of hormone-resistant advanced prostate cancer
4. A decade of experience with chemotherapy for prostate cancer
5. Role of the MDR-1 encoded multidrug resistance phenotype in prostate cancer cell lines
6. Multidrug resistance in androgen-independent growing rat prostate cardnoma cells is mediated by P-glycoprotein
7. Establishment and in vivo characterization of multidrug resistant Dunning R3327 rat prostate-carcinoma ceil lines
8. Reversal by a dihydropyridine derivative of non-pglycoproteinmediated multidrug resistance in a etoposide-resistant human prostatic cancer cell line
9. Chemosensitivity of prostate cancer cell lines and expression of multidrug resistance-related proteins
10. Isolation and expression of a complementary DNA that confers multidrug resistance
11. Expression of a full-length cDNA for the human MDR1 gene confers resistance to colchicine, doxorubicin, and vinblastine
12. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells
13. Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs
14. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of multidrug resistance-associated protein gene (MRP1), in human cancer cell lines
15. Activity and expression of the multidrug resistance proteins MRP1 and MRP2 in acute myeloid leukemia cells, tumour cell lines, and normal hematopoietic CD34 + peripheral blood cells
16. A previously unidentified factor in resistance to nucleoside-based antiviral drugs
17. Management of hormone refractory prostate cancer: Current standards and future prospects
18. Chemotherapy for hormone refractory prostate cancer
19. Chromosome mediated gene transfer of drug resistance to mitoxantrone
20. Mitoxantrone, etoposide, and cytarabine plus cyclosporine for patients with relapsed or refractory acute myeloid leukemia
21. Establishment and characterization of a human prostatatic carcinoma cell line (PC-3)
22. Isolation of human prostate carcinoma cell line (DU145)
23. Circumvention of tamoxifen resistance by the pure anti-estrogen ICI 182,780
24. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
25. Isolation and sequence of the promoter region of human multidrug resistance (P-glycoprotein) gene
26. Analysis of MRP mRNA in mitoxantrone selected multidrug resistant human tumor cells
27. Quantitative analysis of MDR1 (multi-drug resistance) gene expression in human tumours by polymerase chain reaction
28. Quantitative polymerase chain reaction analysis of mdr1 mRNA in multiple myeloma cell lines and clinical specimens
29. Isolation of DNA from mammalians cells
30. Cellular and karyotypic characterization of two doxorubicin resistant cell lines isolated from the same parental human leukemia cell line
31. Overexpression of a transporter gene in a multi-drug-resistant human lung cancer cell line
32. Immunochemical detection of the multi-drug resistance-associated protein MRP in human multidrug resistant tumor cells by monoclonal antibodies
33. Methods to detect P-glycoprotein-associated multidrug resistance in patients tumour. Consensus recommendations
34. Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs
35. Pseudomonas Exotoxin conjugated to monoclonal antibody MRK16 specifically kills multidrug resistant cells in culttured renal cardnomas and MDR-transgenic mice
36. Development of doxorubicin resistant rat prostate cancer cell line
37. Regulation of mdr RNA levels in response to cytotoxic drugs in rodent cells
38. Tissue-specific enhancer of the human multidrug-resistance (MDR1) gene
39. Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines
40. Mechanisms of MRP overexpression in four human lung-cancer cell lines and analysis of MRP amplification
41. Cloning and sequence analysis of the promoter region of the MRP gene of HL6O cells isolated for resistance to adriamycin
42. Analysis of the proximal promoter region of the multidrug resistance protein (MRP) gene in three small cell lung cancer cell lines
43. Androgen-dependent and -independent human prostate xenograft tumour as models for drug activity evaluation
44. A relationship between multi- drug resistance and growth-state dependent cytotoxicity of the lysosomotropic detergent N-dodecylimidazole
45. Development of an intrinsic P-glycoprotein- mediated doxorubicin resistance in quiescent cell layers of large, multicellular prostate tumour spheroids
46. Impact of the cyclin-dependent kinase inhibitor p27Kipl on resistance of tumour cells to anticancer agents
47. Expression of multidrug resistance gene in human cancer
48. The expression of drug resistance gene product during the progression of human prostate cancer
49. Expression of the multidrug resistance associated protein (MRP) gene in human cancers